Viewing Study NCT02096718


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-03-03 @ 12:16 AM
Study NCT ID: NCT02096718
Status: COMPLETED
Last Update Posted: 2016-01-14
First Post: 2014-03-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Afatinib in Subjects With Kidney Dysfunction
Sponsor: Boehringer Ingelheim
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-05
Start Date Type: None
Primary Completion Date: 2014-12
Primary Completion Date Type: ACTUAL
Completion Date: 2014-12
Completion Date Type: ACTUAL
First Submit Date: 2014-03-24
First Submit QC Date: None
Study First Post Date: 2014-03-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-12-09
Results First Submit QC Date: None
Results First Post Date: 2016-01-14
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-12-09
Last Update Post Date: 2016-01-14
Last Update Post Date Type: ESTIMATED